Genenta Science S.p.A. - GNTA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$1.315M
QoQ value delta ($000)
-$8K (-0.6%)
Implied price effect (QoQ)
-1.55%
Shares
Total shares
727,573
QoQ shares delta
+6,897 (+0.96%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (GNTA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Eurizon Capital SGR S.p.A. 662 360,000 0.0%
ALLIANZ SE 430 234,050 0.0%
SmartHarvest Portfolios, LLC 80 43,856 0.03%
Virtu Financial LLC 68 36,913 0.0%
Simplicity Wealth,LLC 34 18,590 0.0%
Ground Swell Capital, LLC 26 14,374 0.03%
Financial Planning Navigators CORP 7 11,371 0.0%
UBS Group AG 5 3,027 0.0%
GAMMA Investing LLC 3 5,389 0.0%
Farther Finance Advisors, LLC 0 3 0.0%